Clinical trials
Phase 1/2 Drug-Related Side Effects and Adverse Reactions trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 5 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangdong Provincial Hospital of Traditional Chinese Medicine | 3 |
| Alliance for Clinical Trials in Oncology | 1 |
| Brigham and Women's Hospital | 1 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Leiden University | 1 |
| OHSU Knight Cancer Institute | 1 |
| Shanghai Juncell Therapeutics | 1 |
| University of California, San Francisco | 1 |
| University of Illinois at Chicago | 1 |
| University of Wisconsin, Madison | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | 12 |
| Psoriasis | 3 |
| Breast Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Radiation Injuries | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Central Nervous System Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.